DK3649237T3 - Nukleinsyre- og aminosyresekvenser fra ikke-humant menneskeabe-adenovirus, vektorer indeholdende samme og anvendelser deraf - Google Patents
Nukleinsyre- og aminosyresekvenser fra ikke-humant menneskeabe-adenovirus, vektorer indeholdende samme og anvendelser deraf Download PDFInfo
- Publication number
- DK3649237T3 DK3649237T3 DK18737898.9T DK18737898T DK3649237T3 DK 3649237 T3 DK3649237 T3 DK 3649237T3 DK 18737898 T DK18737898 T DK 18737898T DK 3649237 T3 DK3649237 T3 DK 3649237T3
- Authority
- DK
- Denmark
- Prior art keywords
- human
- same
- vectors containing
- amino acid
- nucleic acid
- Prior art date
Links
- 241000282693 Cercopithecidae Species 0.000 title 1
- 150000001413 amino acids Chemical group 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 241000701161 unidentified adenovirus Species 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10323—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17179825 | 2017-07-05 | ||
| PCT/EP2018/068291 WO2019008111A1 (en) | 2017-07-05 | 2018-07-05 | AMINO ACID AND NUCLEIC ACID SEQUENCES OF ADENOVIRUS OF NON-HUMAN GREEN APES, VECTORS CONTAINING SAME, AND USES THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3649237T3 true DK3649237T3 (da) | 2022-02-21 |
Family
ID=59295008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18737898.9T DK3649237T3 (da) | 2017-07-05 | 2018-07-05 | Nukleinsyre- og aminosyresekvenser fra ikke-humant menneskeabe-adenovirus, vektorer indeholdende samme og anvendelser deraf |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11098324B2 (da) |
| EP (1) | EP3649237B1 (da) |
| JP (1) | JP7274222B2 (da) |
| KR (1) | KR102582561B1 (da) |
| CN (1) | CN111108192B (da) |
| AU (1) | AU2018295421B2 (da) |
| BR (1) | BR112020000145A2 (da) |
| CA (1) | CA3066962A1 (da) |
| DK (1) | DK3649237T3 (da) |
| ES (1) | ES2906441T3 (da) |
| HU (1) | HUE058778T2 (da) |
| IL (1) | IL271835B2 (da) |
| MX (1) | MX2020000221A (da) |
| PL (1) | PL3649237T3 (da) |
| PT (1) | PT3649237T (da) |
| RU (1) | RU2762854C2 (da) |
| SG (1) | SG11201913178WA (da) |
| WO (1) | WO2019008111A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3587581A1 (en) | 2018-06-26 | 2020-01-01 | GlaxoSmithKline Biologicals S.A. | Formulations for simian adenoviral vectors having enhanced storage stability |
| TW202043256A (zh) | 2019-01-10 | 2020-12-01 | 美商健生生物科技公司 | 前列腺新抗原及其用途 |
| AU2020385683A1 (en) | 2019-11-18 | 2022-06-30 | Janssen Biotech, Inc. | Vaccines based on mutant CALR and JAK2 and their uses |
| TW202144389A (zh) | 2020-02-14 | 2021-12-01 | 美商健生生物科技公司 | 在多發性骨髓瘤中表現之新抗原及其用途 |
| TW202144388A (zh) | 2020-02-14 | 2021-12-01 | 美商健生生物科技公司 | 在卵巢癌中表現之新抗原及其用途 |
| EP4112036A4 (en) | 2020-02-27 | 2024-04-17 | Amorepacific Corporation | COMPOSITION WITH IMPROVED USABILITY |
| JP2023521194A (ja) | 2020-04-13 | 2023-05-23 | ヤンセン バイオテツク，インコーポレーテツド | Ｐｓｍａ及びｓｔｅａｐ１ワクチン並びにそれらの使用 |
| US20230109362A1 (en) | 2020-05-14 | 2023-04-06 | Glaxosmithkline Biologicals Sa | Viral biosensors |
| TW202208398A (zh) * | 2020-07-01 | 2022-03-01 | 義大利商萊伊錫拉有限責任公司 | 大猩猩腺病毒核酸及胺基酸序列，包含彼之載體，及其用途 |
| US20230035403A1 (en) | 2020-07-06 | 2023-02-02 | Janssen Biotech, Inc. | Method For Determining Responsiveness To Prostate Cancer Treatment |
| EP4175664A2 (en) | 2020-07-06 | 2023-05-10 | Janssen Biotech, Inc. | Prostate neoantigens and their uses |
| WO2022007774A1 (zh) * | 2020-07-06 | 2022-01-13 | 嘉兴安宇生物科技有限公司 | 一种新型黑猩猩腺病毒载体及其构建方法和应用 |
| US20230024133A1 (en) | 2020-07-06 | 2023-01-26 | Janssen Biotech, Inc. | Prostate Neoantigens And Their Uses |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0787200T3 (da) | 1994-10-28 | 2005-08-15 | Univ Pennsylvania | Forbedret adenovirus og fremgangsmåder til anvendelse heraf |
| US5922315A (en) | 1997-01-24 | 1999-07-13 | Genetic Therapy, Inc. | Adenoviruses having altered hexon proteins |
| US20030224372A1 (en) | 2002-05-31 | 2003-12-04 | Denise Syndercombe-Court | Method for determining ethnic origin by means of STR profile |
| CA2553541C (en) | 2004-01-23 | 2015-04-21 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Chimpanzee adenovirus vaccine carriers |
| CA2583843C (en) * | 2004-10-13 | 2010-09-21 | Crucell Holland B.V. | Improved adenoviral vectors and uses thereof |
| DE602005025512D1 (de) * | 2004-10-13 | 2011-02-03 | Crucell Holland Bv | Verbesserte adenovirusvektoren und deren verwendung |
| AU2006212885A1 (en) | 2005-02-11 | 2006-08-17 | Merck & Co., Inc. | Adenovirus serotype 26 vectors, nucleic acid and viruses produced thereby |
| JP5809978B2 (ja) * | 2008-10-31 | 2015-11-11 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | サルアデノウイルスＳＡｄＶ−４３、−４５、−４６、−４７、−４８、−４９および−５０ならびにそれらの用途 |
| WO2010085984A1 (en) * | 2009-02-02 | 2010-08-05 | Okairos Ag | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| KR101763093B1 (ko) * | 2009-02-02 | 2017-07-28 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 시미안 아데노바이러스 핵산- 및 아미노산-서열, 이를 포함하는 벡터 및 이의 용도 |
| WO2012023995A1 (en) * | 2010-08-18 | 2012-02-23 | Takayuki Shiratsuchi | Modification of recombinant adenovirus capsid protein with immunogenic plasmodium circumsporozoite protein epitopes |
| WO2013036791A2 (en) * | 2011-09-09 | 2013-03-14 | Beth Israel Deaconess Medical Center, Inc. | Modified adenoviral vectors and methods of treatment using same |
| US9233153B2 (en) * | 2011-10-05 | 2016-01-12 | Genvec, Inc. | Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
| US20150157700A1 (en) * | 2012-02-02 | 2015-06-11 | GanVec, Inc. | Adenoviral vector-based malaria vaccine |
| CN103966263A (zh) * | 2013-02-04 | 2014-08-06 | 广州医学院第一附属医院 | 一种重组人3型腺病毒及其制备方法和应用 |
| CN104419717B (zh) * | 2013-08-23 | 2018-04-27 | 长春百克生物科技股份公司 | 逃避预存免疫的重组腺病毒及其构建方法和用途 |
| WO2019118480A1 (en) * | 2017-12-11 | 2019-06-20 | Beth Israel Deaconess Medical Center, Inc. | Recombinant adenoviruses and uses thereof |
| TW202208398A (zh) * | 2020-07-01 | 2022-03-01 | 義大利商萊伊錫拉有限責任公司 | 大猩猩腺病毒核酸及胺基酸序列，包含彼之載體，及其用途 |
-
2018
- 2018-07-05 RU RU2019144161A patent/RU2762854C2/ru active
- 2018-07-05 KR KR1020207003223A patent/KR102582561B1/ko active IP Right Grant
- 2018-07-05 ES ES18737898T patent/ES2906441T3/es active Active
- 2018-07-05 CN CN201880045366.7A patent/CN111108192B/zh active Active
- 2018-07-05 PL PL18737898T patent/PL3649237T3/pl unknown
- 2018-07-05 SG SG11201913178WA patent/SG11201913178WA/en unknown
- 2018-07-05 AU AU2018295421A patent/AU2018295421B2/en active Active
- 2018-07-05 MX MX2020000221A patent/MX2020000221A/es unknown
- 2018-07-05 US US16/626,438 patent/US11098324B2/en active Active
- 2018-07-05 WO PCT/EP2018/068291 patent/WO2019008111A1/en unknown
- 2018-07-05 DK DK18737898.9T patent/DK3649237T3/da active
- 2018-07-05 PT PT187378989T patent/PT3649237T/pt unknown
- 2018-07-05 JP JP2020500165A patent/JP7274222B2/ja active Active
- 2018-07-05 BR BR112020000145-7A patent/BR112020000145A2/pt unknown
- 2018-07-05 EP EP18737898.9A patent/EP3649237B1/en active Active
- 2018-07-05 HU HUE18737898A patent/HUE058778T2/hu unknown
- 2018-07-05 CA CA3066962A patent/CA3066962A1/en active Pending
-
2020
- 2020-01-05 IL IL271835A patent/IL271835B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102582561B1 (ko) | 2023-09-26 |
| AU2018295421B2 (en) | 2024-01-25 |
| SG11201913178WA (en) | 2020-01-30 |
| RU2019144161A3 (da) | 2021-08-05 |
| WO2019008111A1 (en) | 2019-01-10 |
| IL271835B1 (en) | 2023-04-01 |
| PL3649237T3 (pl) | 2022-03-28 |
| MX2020000221A (es) | 2020-08-13 |
| EP3649237A1 (en) | 2020-05-13 |
| HUE058778T2 (hu) | 2022-09-28 |
| US11098324B2 (en) | 2021-08-24 |
| EP3649237B1 (en) | 2022-01-19 |
| AU2018295421A1 (en) | 2020-01-02 |
| CN111108192A (zh) | 2020-05-05 |
| CN111108192B (zh) | 2023-12-15 |
| RU2019144161A (ru) | 2021-08-05 |
| IL271835A (en) | 2020-02-27 |
| IL271835B2 (en) | 2023-08-01 |
| RU2762854C2 (ru) | 2021-12-23 |
| KR20200024296A (ko) | 2020-03-06 |
| US20210130848A1 (en) | 2021-05-06 |
| JP7274222B2 (ja) | 2023-05-16 |
| JP2020530761A (ja) | 2020-10-29 |
| ES2906441T3 (es) | 2022-04-18 |
| BR112020000145A2 (pt) | 2020-07-14 |
| CA3066962A1 (en) | 2019-01-10 |
| NZ759892A (en) | 2023-09-29 |
| PT3649237T (pt) | 2022-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3649237T3 (da) | Nukleinsyre- og aminosyresekvenser fra ikke-humant menneskeabe-adenovirus, vektorer indeholdende samme og anvendelser deraf | |
| IL271458A (en) | Assessing conditions in transplant subjects using donor-specific cell-free dna | |
| DK3506909T3 (da) | 4'-phosphatanaloger og oligonukleotider omfattende samme | |
| DK3475295T3 (da) | Hidtil ukendt nukleosidtriphosphat-transportør og anvendelser deraf | |
| DK3347472T3 (da) | Sammensætninger som indeholder cyp76ad1- clade polypeptider og anvendelse heraf. | |
| DK3440206T3 (da) | Multimer-kodende nukleinsyre og anvendelser deraf | |
| DK3280432T3 (da) | Polypeptider indeholdende de novo-bindingsdomæner og anvendelser deraf | |
| DK3297637T3 (da) | Benzen-1,3,5-tricarboxamidderivater og anvendelser deraf | |
| DK3484865T3 (da) | Somatostatinmodulatorer og anvendelser deraf | |
| DK3265571T3 (da) | Fler-vektorsystem og anvendelse heraf | |
| DK3580561T3 (da) | Hla-baserede metoder, sammensætninger og anvendelse heraf | |
| HK1246657A1 (zh) | 具有祖先序列的因子viii蛋白、表達載體和與其相關的用途 | |
| IL251571B (en) | Variable proteins comprising the cry1da1 amino acid sequence are activated by lepidopteran | |
| DK3436434T3 (da) | Indolin-analoger og anvendelser deraf | |
| DK3331553T3 (da) | Hidtil ukendte, antihumane gpvi-antistoffer og anvendelser deraf | |
| DK3350343T3 (da) | Fremgangsmåder og sammensætninger til genommålberigelse og selektiv dna-sekventering | |
| PL3359676T3 (pl) | Układ transpozonowy, zestaw zawierający ten układ oraz zastosowania tego układu | |
| DK3608334T3 (da) | Tatk-cdkl5-fusionsproteiner, sammensætninger, formuleringer og anvendelse deraf | |
| IL267445A (en) | An array that includes a genetic tiling primer and a non tiling entity | |
| DK3380115T3 (da) | Peptider fra piwil 1 | |
| DK3383406T3 (da) | Sammensætninger indeholdende decitabin, 5-azacytidin og tetrahydrouridin og anvendelser deraf | |
| DK3590523T3 (da) | Vækstfremmende peptider og anvendelser deraf | |
| IL274215A (en) | Optimization of AGA genes and expression cassettes and their use | |
| DK3589748T3 (da) | Nukleinsyremodifikation og identifikationsfremgangsmåde | |
| DK3438118T3 (da) | Peptidderivat og anvendelse deraf |